FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… Post author:Sam Post published:November 16, 2017 Post category:BioPharma The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018. Source: BioSpace You Might Also Like MacroGenics Announces Registered Direct Offering Of Common Stock April 26, 2017 Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire February 6, 2017 Hikma's Advair Generic Gets Further Delayed March 11, 2018
